Higher Dose Of Cpx-351 Is Associated With Prolonged Hematologic Recovery: Results From An Interim Safety Analysis Of The Randomized, Phase Iii Amlsg 30-18 Trial

BLOOD(2020)

引用 3|浏览28
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要